AI-powered rare disease diagnosis platform connecting undiagnosed patients to testing and treatment
Probably Genetic operates a diagnostic platform combining symptom-checking ML models, direct-to-consumer genetic testing, and treatment matching for rare disease patients. The tech stack (Python, Django, PostgreSQL, React, TypeScript, HL7, FHIR) reflects a regulated healthcare build with clinical interoperability standards. Active hiring is concentrated in marketing and data roles, while infrastructure challenges around patient engagement and scaling suggest the company is balancing rapid patient acquisition with backend stability.
Notable leadership hires: Head of Marketing
Probably Genetic helps undiagnosed rare disease patients obtain genetic testing and diagnosis within weeks instead of the typical 5–7 year diagnostic odyssey. The platform integrates three core functions: an AI-powered symptom checker, direct-to-consumer genetic testing (often subsidized through partnerships with drug developers), and connections to treatments and advocacy communities. The company operates under strict regulatory constraints (HIPAA, CLIA) and targets a market of approximately 200 million undiagnosed rare disease patients globally, with particular focus on pediatric cases. Revenue flows through both patient acquisition and sponsored testing programs funded by pharmaceutical partners.
Python, Django, PostgreSQL, React, TypeScript, AWS, Terraform, GitHub Actions, plus healthcare standards (HL7, FHIR). Iterable and Zapier handle patient communication and workflow automation.
AI-enabled patient experience, genetic sequencing workflows, customer data pipelines, email campaigns, and patient advocacy programs. Current focus areas include automating business processes and scaling infrastructure for global markets.
Other companies in the same industry, closest in size